Events - Spark Newswire

2 minute read

Events
News

Repare Therapeutics To Present Initial Data From The Phase 1/2 TRESR RP-3500 Clinical Trial At AACR-NCI-EORTC Virtual International Conference On Molecular Targets And Cancer Therapeutics

Today, 5:08 AM

Repare Therapeutics Inc. (“Repare” or the “Company”) (NASDAQ:RPTX), a leading clinical-stage precision oncology company, today announced that it has been selected for an oral presentation of

RPTX

2 minute read

Events
News

Kinnate Biopharma Inc. To Present Trial Design For Its Lead RAF Kinase Inhibitor Program At The AACR-NCI-EORTC Virtual International Conference

By Benzinga Newsdesk

Today, 5:08 AM

Kinnate Biopharma Inc. (NASDAQ:KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers,

KNTE

2 minute read

Ascendis Pharma A/S Announces Presentations For TransCon PTH And TransCon CNP At American Society For Bone & Mineral Research 2021 Annual Meeting

By Benzinga Newsdesk

Today, 5:08 AM

Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company using its innovative TransCon technologies to potentially create new treatments to make a meaningful difference in patients' lives, today announced

ASND

1 minute read

From BZ’s Small Cap Healthcare Conference: Exicure CEO, David Giljohann, Ph.D Begins Speaking

By Zoltan Suranyi

Today, 5:08 AM

Click To Tune In Here... https://www.youtube.com/watch?v=TG5SSZDlpBo

XCUR

1 minute read

From BZ’s Small Cap Healthcare Conference: Lineage Cell Therapeutics CEO, Brian M. Culley Begins Speaking

By Zoltan Suranyi

Today, 5:08 AM

Click To Tune In Here... https://www.youtube.com/watch?v=KJGuHiRQ4wE

LCTX

1 minute read

From BZ’s Small Cap Healthcare Conference: TRACON Pharmaceuticals CFO, Scott Brown Begins Speaking

By Zoltan Suranyi

Today, 5:08 AM

Click To Tune In Here... https://www.youtube.com/watch?v=KJGuHiRQ4wE

TCON

1 minute read

From BZ’s Small Cap Healthcare Conference: Cybin CEO Doug Drysdale Begins Presenting

By Michael Horton

Today, 5:08 AM

Click Here To Tune In... https://www.youtube.com/watch?v=TG5SSZDlpBo

CYBN

1 minute read

Scholar Rock Presents Exploratory Responder Analysis On Efficacy Data From Apitegromab TOPAZ Phase 2 Trial At Child Neurology Society Annual Meeting

By Benzinga Newsdesk

Today, 5:08 AM

Scholar Rock (NASDAQ:SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced a late breaker poster

SRRK